Cargando…
Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review
Background Tuberous sclerosis (TS) is a multisystem genetic disease in which epilepsy is a frequent manifestation and is often difficult to control. Everolimus is a drug with proven efficacy in the treatment of other conditions related to TS, and some evidence suggests that its use benefits the tre...
Autores principales: | Menezes, Catarina Ester Gomes, Santos, Débora Lopes dos, Nery, Erick Santos, Serpa, Evelin Duarte, Morais, Lécio Aragão Souza, Dutra, Lucas Santana, Portela Filho, Marcos Baruch, Goes, Julieta Sobreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169230/ https://www.ncbi.nlm.nih.gov/pubmed/36863402 http://dx.doi.org/10.1055/s-0042-1758442 |
Ejemplares similares
-
Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017) -
Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018) -
Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018) -
Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex
por: Lanfranco, Julio, et al.
Publicado: (2021) -
Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex
por: Daccord, Cécile, et al.
Publicado: (2020)